Literature DB >> 533255

Rifampin plus trimethoprim: bactericidal activity and suppression of resistance in human urine in vitro.

B P Goldstein, I F Ripamonti, G Bolzoni, G Carniti, V Arioli.   

Abstract

The bactericidal effect of a combination of rifampin (Ramp) and trimethoprim (Tmp) was studied using dense cultures of test organisms, including some urinary pathogens, growing in human urine. Drug concentrations used were similar to those attainable in human urine. The combination was more effective than the individual drugs and than a combination of Tmp plus sulfamethoxazole (Smx). Tmp was bactericidal in urine and blocked the emergence of Ramp-resistant bacteria. Ramp was responsible for most of the bactericidal action of the combination but also potentiated the bactericidal activity of Tmp. Ramp suppressed the selection of thy- (Tmp-resistant) bacteria. Under the experimental conditions, Smx+Tmp was not more bactericidal than Tmp alone for most of the test organisms, despite strong synergy between the two at subinhibitory concentrations.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 533255      PMCID: PMC352945          DOI: 10.1128/AAC.16.6.736

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  21 in total

1.  IMPROVED METHOD FOR THE ISOLATION OF THYMINE-REQUIRING MUTANTS OF ESCHERICHIA COLI.

Authors:  K A STACEY; E SIMSON
Journal:  J Bacteriol       Date:  1965-08       Impact factor: 3.490

2.  Mutants of Escherichia coli requiring methionine or vitamin B12.

Authors:  B D DAVIS; E S MINGIOLI
Journal:  J Bacteriol       Date:  1950-07       Impact factor: 3.490

3.  The action of trimethoprim and rifampicin in combination against Gram-negative rods resistant to gentamicin.

Authors:  W Farrell; M Wilks; F A Drasar
Journal:  J Antimicrob Chemother       Date:  1977-09       Impact factor: 5.790

4.  Interaction between rifampicin and trimethoprim in vitro and in experimental infections.

Authors:  V Arioli; M Berti; G Carniti; E Rossi
Journal:  J Antimicrob Chemother       Date:  1977-01       Impact factor: 5.790

5.  The use of antibiotic combinations in the treatment of Serratia marcescens infections.

Authors:  J M Hamilton-Miller; D W Kerry; W Brumfitt
Journal:  J Antimicrob Chemother       Date:  1977-03       Impact factor: 5.790

6.  Thymidine concentrations in serum and urine of different animal species and man.

Authors:  H Nottebrock; R Then
Journal:  Biochem Pharmacol       Date:  1977-11-15       Impact factor: 5.858

7.  The interactions between rifampicin and trimethoprim: an in vitro study.

Authors:  R N Grüneberg; A M Emmerson
Journal:  J Antimicrob Chemother       Date:  1977-09       Impact factor: 5.790

8.  Human infections with thymine-requiring bacteria.

Authors:  R Maskell; O A Okubadejo; R H Payne; L Pead
Journal:  J Med Microbiol       Date:  1978-02       Impact factor: 2.472

9.  Effect of thymidine on activity of trimethoprim and sulphamethoxazole.

Authors:  A Stokes; R W Lacey
Journal:  J Clin Pathol       Date:  1978-02       Impact factor: 3.411

10.  Controlled clinical trial of a rifampicin- trimethoprim combination (Rifaprim) and cotrimoxazole in patients with chronic urinary tract infections.

Authors:  T Adachi; T R de Almeida
Journal:  J Int Med Res       Date:  1979       Impact factor: 1.671

View more
  4 in total

1.  Anti-folates potentiate bactericidal effects of other antimicrobial agents.

Authors:  Kun Li; Xu-de Wang; Shan-Shan Yang; Jing Gu; Jiao-Yu Deng; Xian-En Zhang
Journal:  J Antibiot (Tokyo)       Date:  2017-01-11       Impact factor: 2.649

2.  Randomized clinical trial of rifampin-trimethoprim and sulfamethoxazole-trimethoprim in the treatment of localized urinary tract infections.

Authors:  G E Stein; D Gurwith; M Gurwith
Journal:  Antimicrob Agents Chemother       Date:  1988-06       Impact factor: 5.191

3.  Trimethoprim-rifampin, a new combination agent: efficacy in localized urinary infection and influence on microflora.

Authors:  A M Bourgault; K R Forward; A R Ronald; G K Harding; M Thomson; G Grey
Journal:  Antimicrob Agents Chemother       Date:  1981-04       Impact factor: 5.191

Review 4.  Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.

Authors:  G P Wormser; G T Keusch; R C Heel
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.